Eosinophilic esophagitis is characterized by a non-IgE-mediated food hypersensitivity

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 71, Issue 5, 2016, Pages 611-620

  Simon, D ^a   Cianferoni, A ^b,c   Spergel, J M ^b,c   Aceves, S ^d   Holbreich, M ^e   Venter, C ^f,g   Rothenberg, M E ^f   Terreehorst, I ^h   Muraro, A ⁱ   Lucendo, A J ^j   Schoepfer, A ^k   Straumann, A ^l   Simon, H U ^m  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d Inflammation and Immunology   (United States)

^e Allergy and Asthma Consultants   (United States)

^f CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^g UNIVERSITY OF PORTSMOUTH   (United Kingdom)

^h ACADEMIC MEDICAL CENTER   (Netherlands)

ⁱ UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^j Hospital General de Tomelloso   (Spain)

^k LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^l Chairman Swiss EoE Research Group   (Switzerland)

^m UNIVERSITY OF BERN   (Switzerland)

more..

Author keywords

eosinophilic esophagitis; epithelial barrier; food allergy; immune response; immunoglobulin E

Indexed keywords

CD40 LIGAND; EOTAXIN 3; IMMUNOGLOBULIN E; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 23; INTERLEUKIN 5; INTERLEUKIN 5 RECEPTOR ALPHA; INTERLEUKIN 6; INTERLEUKIN 8; INTERLEUKIN 9; OMALIZUMAB; THYMIC STROMAL LYMPHOPOIETIN; TUMOR NECROSIS FACTOR ALPHA; ALLERGEN; ANTIASTHMATIC AGENT;

ADAPTIVE IMMUNITY; CROHN DISEASE; DRUG HYPERSENSITIVITY; EOSINOPHILIC ESOPHAGITIS; FOOD ALLERGY; HUMAN; INNATE IMMUNITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SENSITIZATION; SKIN ALLERGY; TH2 CELL; ULCERATIVE COLITIS; EPITHELIUM; FOOD; HYPERSENSITIVITY; IMMUNOLOGY; INFLAMMATORY BOWEL DISEASE; METABOLISM; PATHOLOGY; SKIN; TREATMENT OUTCOME;

ALLERGENS; ANTI-ASTHMATIC AGENTS; EOSINOPHILIC ESOPHAGITIS; EPITHELIUM; FOOD; FOOD HYPERSENSITIVITY; HUMANS; HYPERSENSITIVITY; IMMUNITY, INNATE; IMMUNOGLOBULIN E; INFLAMMATORY BOWEL DISEASES; OMALIZUMAB; SKIN; TH2 CELLS; TREATMENT OUTCOME;

EID: 84959422890     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12846     Document Type: Review

References (101)

1. Furuta GT, Liacouras CA, Collins MH, Gupta SK, Justinich C, Putnam PE, et al., Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology 2007; 133: 1342-1363.
2. Liacouras CA, Furuta GT, Hirano I, Atkins D, Attwood SE, Bonis PA, et al., Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol 2011; 128: 3-20.
3. Furuta GT, Katzka DA,. Eosinophilic esophagitis. N Engl J Med 2015; 373: 1640-1648.
4. Wen T, Dellon ES, Moawad FJ, Furuta GT, Aceves SS, Rothenberg ME,. Transcriptome analysis of proton pump inhibitor-responsive esophageal eosinophilia reveals proton pump inhibitor-reversible allergic inflammation. J Allergy Clin Immunol 2015; 135: 187-197.
5. Molina-Infante J, Bredenoord AJ, Cheng E, Dellon ES, Furuta GT, Gupta SK, et al., Proton pump inhibitor-responsive oesophageal eosinophilia: an entity challenging current diagnostic criteria for eosinophilic oesophagitis. Gut 2015; 65: 524-531.
6. Eluri S, Dellon ES,. Proton pump inhibitor-responsive oesophageal eosinophilia and eosinophilic oesophagitis: more similarities than differences. Curr Opin Gastroenterol 2015; 31: 309-315.
7. Attwood SE, Smyrk TC, Demeester TR, Jones JB,. Esophageal eosinophilia with dysphagia, a distinct clinicopathologic syndrome. Dig Dis Sci 1993; 38: 109-116.
8. Straumann A, Spichtin HP, Bernoulli R, Loosli J, Vögtlin J,. Idiopathic eosinophilic esophagitis: a frequently overlooked disease with typical clinical aspects and discrete endoscopic findings. Schweiz Med Wochenschr 1994; 124: 1419-1429.
9. Kelly KJ, Lazenby AJ, Rowe PC, Yardley JH, Perman JA, Sampson HA,. Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula. Gastroenterology 1995; 109: 1503-1512.
10. Straumann A, Aceves SS, Blanchard C, Collins MH, Furuta GT, Hirano I, et al., Pediatric and adult eosinophilic esophagitis: similarities and differences. Allergy 2012; 67: 477-490.
11. Assa'ad AH, Putnam PE, Collins MH, Akers RM, Jameson SC, Kirby CL, et al., Pediatric patients with eosinophilic esophagitis: an 8-year follow-up. J Allergy Clin Immunol 2007; 119: 731-738.
12. Sugnanam KK, Collins JT, Smith PK, Connor F, Lewindon P, Cleghorn G, et al., Dichotomy of food and inhalant allergen sensitization in eosinophilic esophagitis. Allergy 2007; 62: 1257-1260.
13. Spergel JM, Beausoleil JL, Mascarenhas M, Liacouras CA,. The use of skin prick tests and patch tests to identify causative foods in eosinophilic esophagitis. J Allergy Clin Immunol 2002; 109: 363-368.
14. Simon D, Straumann A, Dahinden C, Simon HU,. Frequent sensitization to Candida albicans and profilins in adult eosinophilic esophagitis. Allergy 2013; 68: 945-948.
15. Vicario M, Blanchard C, Stringer KF, Collins MH, Mingler MK, Ahrens A, et al., Local B cells and IgE production in the oesophageal mucosa in eosinophilic oesophagitis. Gut 2010; 59: 12-20.
16. Spergel JM, Brown-Whitehorn TF, Cianferoni A, Shuker M, Wang ML, Verma R, et al., Identification of causative foods in children with eosinophilic esophagitis treated with an elimination diet. J Allergy Clin Immunol 2012; 130: 461-467.
17. Henderson CJ, Abonia JP, King EC, Putnam PE, Collins MH, Franciosi JP, et al., Comparative dietary therapy effectiveness in remission of pediatric eosinophilic esophagitis. J Allergy Clin Immunol 2012; 129: 1570-1578.
18. Simon D, Straumann A, Wenk A, Spichtin H, Simon HU, Braathen LR,. Eosinophilic esophagitis in adults-no clinical relevance of wheat and rye sensitizations. Allergy 2006; 61: 1480-1483.
19. Spergel JM, Andrews T, Brown-Whitehorn TF, Beausoleil JL, Liacouras CA,. Treatment of eosinophilic esophagitis with specific food elimination diet directed by a combination of skin prick and patch tests. Ann Allergy Asthma Immunol 2005; 95: 336-343.
20. Loizou D, Enav B, Komlodi-Pasztor E, Hider P, Kim-Chang J, Noonan L, et al., A pilot study of omalizumab in eosinophilic esophagitis. PLoS One 2015; 10: e0113483.
21. Clayton F, Fang JC, Gleich GJ, Lucendo AJ, Olalla JM, Vinson LA, et al., Eosinophilic esophagitis in adults is associated with IgG4 and not mediated by IgE. Gastroenterology 2014; 147: 602-609.
22. Straumann A, Bauer M, Fischer B, Blaser K, Simon HU,. Idiopathic eosinophilic esophagitis is associated with a T(H)2-type allergic inflammatory response. J Allergy Clin Immunol 2001; 108: 954-961.
23. Blanchard C, Wang N, Stringer KF, Mishra A, Fulkerson PC, Abonia JP, et al., Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J Clin Invest 2006; 116: 536-547.
24. Blanchard C, Stucke EM, Rodriguez-Jimenez B, Burwinkel K, Collins MH, Ahrens A, et al., A striking local esophageal cytokine expression profile in eosinophilic esophagitis. J Allergy Clin Immunol 2011; 127: 208-217.
25. Mishra A, Hogan SP, Brandt EB, Rothenberg ME,. An etiological role for aeroallergens and eosinophils in experimental esophagitis. J Clin Invest 2001; 107: 83-90.
26. Mishra A, Rothenberg ME,. Intratracheal IL-13 induces eosinophilic esophagitis by an IL-5, eotaxin-1, and STAT6-dependent mechanism. Gastroenterology 2003; 125: 1419-1427.
27. Kohan M, Puxeddu I, Reich R, Levi-Schaffer F, Berkman N,. Eotaxin-2/CCL24 and eotaxin-3/CCL26 exert differential profibrogenic effects on human lung fibroblasts. Ann Allergy Asthma Immunol 2010; 104: 66-72.
28. Zuo L, Fulkerson PC, Finkelman FD, Mingler M, Fischetti CA, Blanchard C, et al., IL-13 induces esophageal remodeling and gene expression by an eosinophil-independent, IL-13R alpha 2-inhibited pathway. J Immunol 2010; 185: 660-669.
29. Blanchard C, Mingler MK, Vicario M, Abonia JP, Wu YY, Lu TX, et al., IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoids. J Allergy Clin Immunol 2007; 120: 1292-1300.
30. Straumann A, Conus S, Grzonka P, Kita H, Kephart G, Bussmann C, et al., Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial. Gut 2010; 59: 21-30.
31. Rothenberg ME, Wen T, Greenberg A, Alpan O, Enav B, Hirano I, et al., Intravenous anti-IL-13 mAb QAX576 for the treatment of eosinophilic esophagitis. J Allergy Clin Immunol 2015; 135: 500-507.
32. Martin SF,. Allergic contact dermatitis: xenoinflammation of the skin. Curr Opin Immunol 2012; 24: 720-729.
33. Martin SF,. New concepts in cutaneous allergy. Contact Dermatitis 2015; 72: 2-10.
34. Kehren J, Desvignes C, Krasteva M, Ducluzeau MT, Assossou O, Horand F, et al., Cytotoxicity is mandatory for CD8(+) T cell-mediated contact hypersensitivity. J Exp Med 1999; 189: 779-786.
35. Pennino D, Eyerich K, Scarponi C, Carbone T, Eyerich S, Nasorri F, et al., IL-17 amplifies human contact hypersensitivity by licensing hapten nonspecific Th1 cells to kill autologous keratinocytes. J Immunol 2010; 184: 4880-4888.
36. Simon D, Radonjic-Hösli S, Straumann A, Yousefi S, Simon HU,. Active eosinophilic esophagitis is characterized by epithelial barrier defects and eosinophil extracellular trap formation. Allergy 2015; 70: 443-452.
37. Martin SF, Esser PR, Schmucker S, Dietz L, Naisbitt DJ, Park BK, et al., T-cell recognition of chemicals, protein allergens and drugs: towards the development of in vitro assays. Cell Mol Life Sci 2010; 67: 4171-4184.
38. Pichler WJ, Naisbitt DJ, Park BK,. Immune pathomechanism of drug hypersensitivity reactions. J Allergy Clin Immunol 2011; 127: 74-81.
39. Demoly P, Adkinson NF, Brockow K, Castells M, Chiriac AM, Greenberger PA, et al., International Consensus on drug allergy. Allergy 2014; 69: 420-437.
40. Yawalkar N, Egli F, Hari Y, Nievergelt H, Braathen LR, Pichler WJ,. Infiltration of cytotoxic T cells in drug-induced cutaneous eruptions. Clin Exp Allergy 2000; 30: 847-855.
41. Schmid S, Kuechler PC, Britschgi M, Steiner UC, Yawalkar N, Limat A, et al., Acute generalized exanthematous pustulosis: role of cytotoxic T cells in pustule formation. Am J Pathol 2002; 161: 2079-2086.
42. Picard D, Janela B, Descamps V, D'Incan M, Courville P, Jacquot S, et al., Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response. Sci Transl Med 2010; 2: 46-62.
43. Akdis CA, Akdis M, Simon D, Dibbert B, Weber M, Gratzl S, et al., T cells and T cell-derived cytokines as pathogenic factors in the nonallergic form of atopic dermatitis. J Invest Dermatol 1999; 113: 628-634.
44. Breuer K, Heratizadeh A, Wulf A, Baumann U, Constien A, Tetau D, et al., Late eczematous reactions to food in children with atopic dermatitis. Clin Exp Allergy 2004; 34: 817-824.
45. Reekers R, Beyer K, Niggemann B, Wahn U, Freihorst J, Kapp A, et al., The role of circulating food antigen-specific lymphocytes in food allergic children with atopic dermatitis. Br J Dermatol 1996; 135: 935-941.
46. Reekers R, Busche M, Wittmann M, Kapp A, Werfel T,. Birch pollen-related foods trigger atopic dermatitis in patients with specific cutaneous T-cell responses to birch pollen antigens. J Allergy Clin Immunol 1999; 104: 466-472.
47. Darsow U, Laifaoui J, Kerschenlohr K, Wollenberg A, Przybilla B, Wüthrich B, et al., The prevalence of positive reactions in the atopy patch test with aeroallergens and food allergens in subjects with atopic eczema: a European multicenter study. Allergy 2004; 59: 1318-1325.
48. Yamazaki K, Murray JA, Arora AS, Alexander JA, Smyrk TC, Butterfield JH, et al., Allergen-specific in vitro cytokine production in adult patients with eosinophilic esophagitis. Dig Dis Sci 2006; 51: 1934-1941.
49. Brough HA, Cousins DJ, Munteanu A, Wong YF, Sudra A, Makinson K, et al., IL-9 is a key component of memory Th cell peanut-specific responses from children with peanut allergy. J Allergy Clin Immunol 2014; 134: 1329-1338.
50. Simon D, Marti H, Heer P, Simon HU, Braathen LR, Straumann A,. Eosinophilic esophagitis is frequently associated with IgE-mediated allergic airway diseases. J Allergy Clin Immunol 2005; 115: 1090-1092.
51. Noti M, Kim BS, Siracusa MC, Rak GD, Kubo M, Moghaddam AE, et al., Exposure to food allergens through inflamed skin promotes intestinal food allergy through the thymic stromal lymphopoietin-basophil axis. J Allergy Clin Immunol 2014; 133: 1390-1399.
52. He R, Kim HY, Yoon J, Oyoshi MK, MacGinnitie A, Goya S, et al., Exaggerated IL-17 response to epicutaneous sensitization mediates airway inflammation in the absence of IL-4 and IL-13. J Allergy Clin Immunol 2009; 124: 761-770.
53. Marenholz I, Nickel R, Rüschendorf F, Schulz F, Esparza-Gordillo J, Kerscher T, et al., Filaggrin loss-of-function mutations predispose to phenotypes involved in the atopic march. J Allergy Clin Immunol 2006; 118: 866-871.
54. Brown SJ, Asai Y, Cordell HJ, Campbell LE, Zhao Y, Liao H, et al., Loss-of-function variants in the filaggrin gene are a significant risk factor for peanut allergy. J Allergy Clin Immunol 2011; 127: 661-667.
55. Blanchard C, Stucke EM, Burwinkel K, Caldwell JM, Collins MH, Ahrens A, et al., Coordinate interaction between IL-13 and epithelial differentiation cluster genes in eosinophilic esophagitis. J Immunol 2010; 184: 4033-4041.
56. Kiran KC, Rothenberg ME, Sherrill JD,. In vitro model for studying esophageal epithelial differentiation and allergic inflammatory responses identifies keratin involvement in eosinophilic esophagitis. PLoS One 2015; 10: e0127755.
57. Sherrill JD, Kc K, Wu D, Djukic Z, Caldwell JM, Stucke EM, et al., Desmoglein-1 regulates esophageal epithelial barrier function and immune responses in eosinophilic esophagitis. Mucosal Immunol 2014; 7: 718-729.
58. Capocelli KE, Fernando SD, Menard-Katcher C, Furuta GT, Masterson JC, Wartchow EP,. Ultrastructural features of eosinophilic oesophagitis: impact of treatment on desmosomes. J Clin Pathol 2015; 68: 51-56.
59. Katzka DA, Tadi R, Smyrk TC, Katarya E, Sharma A, Geno DM, et al., Effects of topical steroids on tight junction proteins and spongiosis in esophageal epithelia of patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol 2014; 12: 1824-1829.
60. Samuelov L, Sarig O, Harmon RM, Rapaport D, Ishida-Yamamoto A, Isakov O, et al., Desmoglein 1 deficiency results in severe dermatitis, multiple allergies and metabolic wasting. Nat Genet 2013; 45: 1244-1248.
61. Hovnanian A,. Netherton syndrome: skin inflammation and allergy by loss of protease inhibition. Cell Tissue Res 2013; 351: 289-300.
62. Roan F, Bell BD, Stoklasek TA, Kitajima M, Han H, Ziegler SF,. The multiple facets of thymic stromal lymphopoietin (TSLP) during allergic inflammation and beyond. J Leukoc Biol 2012; 91: 877-886.
63. Morshed M, Yousefi S, Stöckle C, Simon HU, Simon D,. Thymic stromal lymphopoietin stimulates the formation of eosinophil extracellular traps. Allergy 2012; 67: 1127-1137.
64. Rothenberg ME, Spergel JM, Sherrill JD, Annaiah K, Martin LJ, Cianferoni A, et al., Common variants at 5q22 associate with pediatric eosinophilic esophagitis. Nat Genet 2010; 42: 289-291.
65. Sherrill JD, Gao PS, Stucke EM, Blanchard C, Collins MH, Putnam PE, et al., Variants of thymic stromal lymphopoietin and its receptor associate with eosinophilic esophagitis. J Allergy Clin Immunol 2010; 126: 160-165.
66. Kottyan LC, Davis BP, Sherrill JD, Liu K, Rochman M, Kaufman K, et al., Genome-wide association analysis of eosinophilic esophagitis provides insight into the tissue specificity of this allergic disease. Nat Genet 2014; 46: 895-900.
67. Sleiman PM, Wang ML, Cianferoni A, Aceves S, Gonsalves N, Nadeau K, et al., GWAS identifies four novel eosinophilic esophagitis loci. Nat Commun 2014; 5: 5593.
68. Harris JK, Fang R, Wagner BD, Choe HN, Kelly CJ, Schroeder S, et al., Esophageal microbiome in eosinophilic esophagitis. PLoS One 2015; 10: e0128346.
69. Benitez AJ, Hoffmann C, Muir AB, Dods KK, Spergel JM, Bushman FD, et al., Inflammation-associated microbiota in pediatric eosinophilic esophagitis. Microbiome 2015; 3: 23.
70. Erwin EA, James HR, Gutekunst HM, Russo JM, Kelleher KJ, Platts-Mills TA,. Serum IgE measurement and detection of food allergy in pediatric patients with eosinophilic esophagitis. Ann Allergy Asthma Immunol 2010; 104: 496-502.
71. Corridoni D, Arseneau KO, Cominelli F,. Inflammatory bowel disease. Immunol Lett 2014; 161: 231-235.
72. Xavier RJ, Podolsky DK,. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007; 448: 427-434.
73. Huttenhower C, Kostic AD, Xavier RJ,. Inflammatory bowel disease as a model for translating the microbiome. Immunity 2014; 40: 843-854.
74. Cianferoni A, Spergel JM,. Food allergy: review, classification and diagnosis. Allergol Int 2009; 58: 457-466.
75. Nowak-Wegrzyn A, Sampson HA,. Adverse reactions to foods. Med Clin North Am 2006; 90: 97-127.
76. Simons FE,. Anaphylaxis. J Allergy Clin Immunol 2010; 125: 161-181.
77. Nowak-Wegrzyn A, Muraro A,. Food protein-induced enterocolitis syndrome. Curr Opin Allergy Clin Immunol 2009; 9: 371-377.
78. Venter C, Groetch M,. Nutritional management of food protein-induced enterocolitis syndrome. Curr Opin Allergy Clin Immunol 2014; 14: 255-262.
79. Ruffner MA, Ruymann K, Barni S, Cianferoni A, Brown-Whitehorn T, Spergel JM,. Food protein-induced enterocolitis syndrome: insights from review of a large referral population. J Allergy Clin Immunol Pract 2013; 1: 343-349.
80. Berin MC,. Immunopathophysiology of food protein-induced enterocolitis syndrome. J. Allergy Clin Immunol 2015; 135: 1108-1113.
81. Rocha R, Vitor AB, Trindade E, Lima R, Tavares M, Lopes J, et al., Omalizumab in the treatment of eosinophilic esophagitis and food allergy. Eur J Pediatr 2011; 170: 1471-1474.
82. Kagalwalla AF, Sentongo TA, Ritz S, Hess T, Nelson SP, Emerick KM, et al., Effect of six-food elimination diet on clinical and histologic outcomes in eosinophilic esophagitis. Clin Gastroenterol Hepatol 2006; 4: 1097-1102.
83. Gonsalves N, Yang GY, Doerfler B, Ritz S, Ditto AM, Hirano I,. Elimination diet effectively treats eosinophilic esophagitis in adults; food reintroduction identifies causative factors. Gastroenterology 2012; 142: 1451-1459.
84. Liacouras CA, Spergel JM, Ruchelli E, Verma R, Mascarenhas M, Semeao E, et al., Eosinophilic esophagitis: a 10-year experience in 381 children. Clin Gastroenterol Hepatol 2005; 3: 1198-1206.
85. Spergel JM, Brown-Whitehorn TF, Beausoleil JL, Franciosi J, Shuker M, Verma R, et al., 14 years of eosinophilic esophagitis: clinical features and prognosis. J Pediatr Gastroenterol Nutr 2009; 48: 30-36.
86. Arias A, Gonzalez-Cervera J, Tenias JM, Lucendo AJ,. Efficacy of dietary interventions for inducing histologic remission in patients with eosinophilic esophagitis: a systematic review and meta-analysis. Gastroenterology 2014; 146: 1639-1648.
87. Lee D, Albenberg L, Compher C, Baldassano R, Piccoli D, Lewis JD, et al., Diet in the pathogenesis and treatment of inflammatory bowel diseases. Gastroenterology 2015; 148: 1087-1106.
88. Kagalwalla AF, Shah A, Li BU, Sentongo TA, Ritz S, Manuel-Rubio M, et al., Identification of specific foods responsible for inflammation in children with eosinophilic esophagitis successfully treated with empiric elimination diet. J Pediatr Gastroenterol Nutr 2011; 53: 145-149.
89. Molina-Infante J, Arias A, Barrio J, Rodríguez-Sánchez J, Sanchez-Cazalilla M, Lucendo AJ,. Four-food group elimination diet for adult eosinophilic esophagitis: A prospective multicenter study. J Allergy Clin Immunol 2014; 134: 1093-1099.
90. van Rhijn BD, Vlieg-Boerstra BJ, Versteeg SA, Akkerdaas JH, van Ree R, Terreehorst I, et al., Evaluation of allergen-microarray-guided dietary intervention as treatment of eosinophilic esophagitis. J Allergy Clin Immunol 2015; 136: 1095-1097.
91. Lucendo AJ, Arias A, Tenias JM,. Relation between eosinophilic esophagitis and oral immunotherapy for food allergy: a systematic review with meta-analysis. Ann Allergy Asthma Immunol 2014; 113: 624-629.
92. Ridolo E, De Angelis GL, Dall'aglio P,. Eosinophilic esophagitis after specific oral tolerance induction for egg protein. Ann Allergy Asthma Immunol 2011; 106: 73-74.
93. Miehlke S, Alpan O, Schroeder S, Straumann A,. Induction of eosinophilic esophagitis by sublingual pollen immunotherapy. Case Rep Gastroenterol 2013; 7: 363-368.
94. Maggadottir SM, Hill DA, Ruymann K, Brown-Whitehorn TF, Cianferoni A, Shuker M, et al., Resolution of acute IgE-mediated allergy with development of eosinophilic esophagitis triggered by the same food. J Allergy Clin Immunol 2014; 133: 1487-1489.
95. Niranjan R, Mavi P, Rayapudi M, Dynda S, Mishra A,. Pathogenic role of mast cells in experimental eosinophilic esophagitis. Am J Physiol Gastrointest Liver Physiol 2013; 304: 1087-1094.
96. Noti M, Wojno ED, Kim BS, Siracusa MC, Giacomin PR, Nair MG, et al., Thymic stromal lymphopoietin-elicited basophil responses promote eosinophilic esophagitis. Nat Med 2013; 19: 1005-1013.
97. Schoepfer AM, Safroneeva E, Bussmann C, Kuchen T, Portmann S, Simon HU, et al., Delay in diagnosis of eosinophilic esophagitis increases risk for stricture formation in a time-dependent manner. Gastroenterology 2013; 145: 1230-1236.
98. Dellon ES, Kim HP, Sperry SL, Rybnicek DA, Woosley JT, Shaheen NJ,. A phenotypic analysis shows that eosinophilic esophagitis is a progressive fibrostenotic disease. Gastrointest Endosc 2014; 79: 577-585.
99. Straumann A,. Treatment of eosinophilic esophagitis: diet, drugs, or dilation? Gastroenterology 2012; 142: 1409-1411.
100. Lucendo AJ, Arias A, Gonzalez-Cervera J, Yague-Compadre JL, Guagnozzi D, Angueira T, et al., Empiric 6-food elimination diet induced and maintained prolonged remission in patients with adult eosinophilic esophagitis: a prospective study in the food cause of the disease. J Allergy Clin Immunol 2013; 131: 797-804.
101. Wen T, Stucke EM, Grotjan TM, Kemme KA, Abonia JP, Putnam PE, et al., Molecular diagnosis of eosinophilic esophagitis by gene expression profiling. Gastroenterology 2013; 145: 1289-1299.